Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Pereira, Gerard; Gillies, Hunter; Chanda, Sanjay; Corbett, Michael; Vernon, Suzanne D; Milani, Tina; Bateman, Lucinda

Pereira, Gerard; Gillies, Hunter; Chanda, Sanjay; Corbett, Michael; Vernon, Suzanne D; Milani, Tina; Bateman, Lucinda.

Afiliação

Pereira G; Cortene Inc., Burlingame, CA, United States.
Gillies H; Cortene Inc., Burlingame, CA, United States.
Chanda S; Cortene Inc., Burlingame, CA, United States.
Corbett M; Cortene Inc., Burlingame, CA, United States.
Vernon SD; Bateman Horne Center, Salt Lake City, UT, United States.
Milani T; Bateman Horne Center, Salt Lake City, UT, United States.
Bateman L; Bateman Horne Center, Salt Lake City, UT, United States.

Front Syst Neurosci ; 15: 698240, 2021.

Article em En | MEDLINE | ID: mdl-34539356

Palavras-chave

CRF2; ME/CFS; agonist-mediated receptor endocytosis; corticotropin-releasing factor receptor 2; homeostasis; myalgic encephalomyelitis chronic fatigue syndrome; serotonin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article